109 related articles for article (PubMed ID: 38776910)
1. SERSomes for metabolic phenotyping and prostate cancer diagnosis.
Bi X; Wang J; Xue B; He C; Liu F; Chen H; Lin LL; Dong B; Li B; Jin C; Pan J; Xue W; Ye J
Cell Rep Med; 2024 Jun; 5(6):101579. PubMed ID: 38776910
[TBL] [Abstract][Full Text] [Related]
2. Surface-enhanced Raman scattering (SERS) spectroscopy for prostate cancer diagnosis: A review.
Haroon M; Tahir M; Nawaz H; Majeed MI; Al-Saadi AA
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102690. PubMed ID: 34921990
[TBL] [Abstract][Full Text] [Related]
3. Cancer screening through surface-enhanced Raman spectroscopy fingerprinting analysis of urinary metabolites using surface-carbonized silver nanowires on a filter membrane.
Yu HJ; Jang E; Woo A; Han IW; Jeon HG; Linh VTN; Park SG; Jung HS; Lee MY
Anal Chim Acta; 2024 Mar; 1292():342233. PubMed ID: 38309850
[TBL] [Abstract][Full Text] [Related]
4. When surface-enhanced Raman spectroscopy meets complex biofluids: A new representation strategy for reliable and comprehensive characterization.
He C; Liu F; Wang J; Bi X; Pan J; Xue W; Qian X; Chen Z; Ye J
Anal Chim Acta; 2024 Jul; 1312():342767. PubMed ID: 38834270
[TBL] [Abstract][Full Text] [Related]
5. Intracellular metabolic profiling of drug resistant cells by surface enhanced Raman scattering.
Liu F; Wu T; Tian A; He C; Bi X; Lu Y; Yang K; Xia W; Ye J
Anal Chim Acta; 2023 Oct; 1279():341809. PubMed ID: 37827617
[TBL] [Abstract][Full Text] [Related]
6. Emerging technology: applications of Raman spectroscopy for prostate cancer.
Kast RE; Tucker SC; Killian K; Trexler M; Honn KV; Auner GW
Cancer Metastasis Rev; 2014 Sep; 33(2-3):673-93. PubMed ID: 24510129
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of expressed prostatic secretion and serum using surface-enhanced Raman spectroscopy for the noninvasive detection of prostate cancer, a preliminary study.
Shao X; Pan J; Wang Y; Zhu Y; Xu F; Shangguan X; Dong B; Sha J; Chen N; Chen Z; Wang T; Liu S; Xue W
Nanomedicine; 2017 Apr; 13(3):1051-1059. PubMed ID: 27979746
[TBL] [Abstract][Full Text] [Related]
8. Raman, Infrared and Brillouin Spectroscopies of Biofluids for Medical Diagnostics and for Detection of Biomarkers.
Aitekenov S; Sultangaziyev A; Abdirova P; Yussupova L; Gaipov A; Utegulov Z; Bukasov R
Crit Rev Anal Chem; 2023; 53(7):1561-1590. PubMed ID: 35157535
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics approaches and applications in prostate cancer research.
Zhang A; Yan G; Han Y; Wang X
Appl Biochem Biotechnol; 2014 Sep; 174(1):6-12. PubMed ID: 24838846
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence.
Kelly RS; Vander Heiden MG; Giovannucci E; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):887-906. PubMed ID: 27197278
[TBL] [Abstract][Full Text] [Related]
11. NMR-Based Prostate Cancer Metabolomics.
Euceda LR; Andersen MK; Tessem MB; Moestue SA; Grinde MT; Bathen TF
Methods Mol Biol; 2018; 1786():237-257. PubMed ID: 29786797
[TBL] [Abstract][Full Text] [Related]
12. Label-free determination of prostate specific membrane antigen in human whole blood at nanomolar levels by magnetically assisted surface enhanced Raman spectroscopy.
Chaloupková Z; Balzerová A; Bařinková J; Medříková Z; Šácha P; Beneš P; Ranc V; Konvalinka J; Zbořil R
Anal Chim Acta; 2018 Jan; 997():44-51. PubMed ID: 29149993
[TBL] [Abstract][Full Text] [Related]
13. Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
Zhou L; Liu Y; Wang F; Jia Z; Zhou J; Jiang T; Petti L; Chen Y; Xiong Q; Wang X
Talanta; 2018 Oct; 188():238-244. PubMed ID: 30029370
[TBL] [Abstract][Full Text] [Related]
14. Innovation in metabolomics to improve personalized healthcare.
Cacciatore S; Loda M
Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
[TBL] [Abstract][Full Text] [Related]
15. Untargeted Tumor Metabolomics with Liquid Chromatography-Surface-Enhanced Raman Spectroscopy.
Xiao L; Wang C; Dai C; Littlepage LE; Li J; Schultz ZD
Angew Chem Int Ed Engl; 2020 Feb; 59(9):3439-3443. PubMed ID: 31765069
[TBL] [Abstract][Full Text] [Related]
16. Enabling Sensitive Phenotypic Profiling of Cancer-Derived Small Extracellular Vesicles Using Surface-Enhanced Raman Spectroscopy Nanotags.
Zhang W; Jiang L; Diefenbach RJ; Campbell DH; Walsh BJ; Packer NH; Wang Y
ACS Sens; 2020 Mar; 5(3):764-771. PubMed ID: 32134252
[TBL] [Abstract][Full Text] [Related]
17. Circulating metabolite biomarkers: a game changer in the human prostate cancer diagnosis.
Krishnan S; Kanthaje S; Punchappady DR; Mujeeburahiman M; Ratnacaram CK
J Cancer Res Clin Oncol; 2023 Mar; 149(3):951-967. PubMed ID: 35764700
[TBL] [Abstract][Full Text] [Related]
18. Development of a Correlative Strategy To Discover Colorectal Tumor Tissue Derived Metabolite Biomarkers in Plasma Using Untargeted Metabolomics.
Wang Z; Cui B; Zhang F; Yang Y; Shen X; Li Z; Zhao W; Zhang Y; Deng K; Rong Z; Yang K; Yu X; Li K; Han P; Zhu ZJ
Anal Chem; 2019 Feb; 91(3):2401-2408. PubMed ID: 30580524
[TBL] [Abstract][Full Text] [Related]
19. Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer.
Qian H; Shao X; Zhu Y; Fan L; Zhang H; Dong B; Wang Y; Xu F; Zhen W; Kang X; Chen N; Liu S; Pan J; Xue W
Urol Oncol; 2020 Jun; 38(6):601.e1-601.e9. PubMed ID: 32241690
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
